2008
DOI: 10.1007/s00417-008-0964-7
|View full text |Cite
|
Sign up to set email alerts
|

AlphaCor™ keratoprosthesis: postoperative development of six patients

Abstract: Further evaluation is needed to evaluate the role of AlphaCor as a keratoprosthesis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
12
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 18 publications
0
12
0
Order By: Relevance
“…These keratoprostheses have enjoyed some success, with the Boston keratoprosthesis being placed in over 1000 patients in 2009 (Gomaa et al , 2010). Another device that initially gave promising results was the AlphaCor (Bleckmann and Holak 2006; Hicks et al , 2006), although recent reports have been less encouraging (Chalam et al , 2007; Holak et al , 2009). As an alternative to the use of plastics, several investigations have been made to engineer an artificial cornea using natural compounds, such as collagens, cells and cell lines (Alaminos et al , 2006; Fagerholm et al , 2009; Gonzalez‐Andrades et al , 2009; Huang and Li 2007; Mi et al , 2010; Schneider et al , 1999; Vrana et al , 2008).…”
Section: Discussionmentioning
confidence: 99%
“…These keratoprostheses have enjoyed some success, with the Boston keratoprosthesis being placed in over 1000 patients in 2009 (Gomaa et al , 2010). Another device that initially gave promising results was the AlphaCor (Bleckmann and Holak 2006; Hicks et al , 2006), although recent reports have been less encouraging (Chalam et al , 2007; Holak et al , 2009). As an alternative to the use of plastics, several investigations have been made to engineer an artificial cornea using natural compounds, such as collagens, cells and cell lines (Alaminos et al , 2006; Fagerholm et al , 2009; Gonzalez‐Andrades et al , 2009; Huang and Li 2007; Mi et al , 2010; Schneider et al , 1999; Vrana et al , 2008).…”
Section: Discussionmentioning
confidence: 99%
“…Among them, Boston keratoprosthesis type 1 and 2, the AlphaCor artificial cornea, the Legeais BioKpro III and the osteo-odonto Keratoprosthesis represent the commonest forms [2,7,8]. Although Kpro has gained supporters over the last decade, the management of post-operative complications, especially when posterior segment approach is indicated, remains a challenge [9].…”
Section: Discussionmentioning
confidence: 98%
“…Although several models of KPros have been designed for clinical use, few models have received FDA approval and are currently on the market. 15,28 The most critical problem of clinically approved KPros is bioincompatibility, followed by extrusion, glucoma, and endophthalmitis. Improvements in the design and materials of KPros are therefore necessary to increase tissue biointegration and biocompatibility and to prevent extrusion.…”
Section: Discussionmentioning
confidence: 99%
“…Both parts are made from poly-2-hydroxyethyl methacrylate. 14,15 However, the development of inexpensive and biocompatible materials that can be manufactured using novel and simple techniques is necessary to further improve the biocompatibility of artificial corneas.…”
Section: Introductionmentioning
confidence: 99%